Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lawrence

Showing results (741-750 of 1,074) with videos related to

Pageof 108
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2bB Sirohi, R Powles, D Lawrence, et al.
BMC Neurology|December 5, 2013
The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallenEmily J Henderson, Stephen R Lord, Jacqueline C T Close, et al.
Spine|August 22, 2013
Anterior versus posterior approach for treatment of cervical spondylotic myelopathy: a systematic reviewBrandon D Lawrence, W Bradley Jacobs, Daniel C Norvell, et al.
Communications Biology|September 23, 2022
The interindividual variability of multimodal brain connectivity maintains spatial heterogeneity and relates to tissue microstructureEsin Karahan, Luke Tait, Ruoguang Si, et al.
Journal of Neurology|September 28, 2015
Morphometric changes in the reward system of Parkinson's disease patients with impulse control disordersClelia Pellicano, Flavia Niccolini, Kit Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Model-based method for transcription factor target identification with limited dataAntti Honkela, Charles Girardot, E Hilary Gustafson, et al.
Journal of the National Cancer Institute|February 20, 2003
Effects of tamoxifen on benign breast disease in women at high risk for breast cancerElizabeth Tan-Chiu, Jiping Wang, Joseph P Costantino, et al.
Genes & Development|September 20, 2000
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcriptionJ Zhao, B K Kennedy, B D Lawrence, et al.
Complementary Therapies in Medicine|August 17, 2006
A Phase II study of St. John's Wort for smoking cessationSilvana Lawvere, Martin C Mahoney, K Michael Cummings, et al.
Neuropsychologia|April 5, 2002
Reading the mind from eye gazeAndrew J Calder, Andrew D Lawrence, Jill Keane, et al.
Pageof 108

Showing results (741-750 of 1,074) with videos related to

Sort By:
Pageof 108
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2bB Sirohi, R Powles, D Lawrence, et al.
BMC Neurology|December 5, 2013
The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallenEmily J Henderson, Stephen R Lord, Jacqueline C T Close, et al.
Spine|August 22, 2013
Anterior versus posterior approach for treatment of cervical spondylotic myelopathy: a systematic reviewBrandon D Lawrence, W Bradley Jacobs, Daniel C Norvell, et al.
Communications Biology|September 23, 2022
The interindividual variability of multimodal brain connectivity maintains spatial heterogeneity and relates to tissue microstructureEsin Karahan, Luke Tait, Ruoguang Si, et al.
Journal of Neurology|September 28, 2015
Morphometric changes in the reward system of Parkinson's disease patients with impulse control disordersClelia Pellicano, Flavia Niccolini, Kit Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Model-based method for transcription factor target identification with limited dataAntti Honkela, Charles Girardot, E Hilary Gustafson, et al.
Journal of the National Cancer Institute|February 20, 2003
Effects of tamoxifen on benign breast disease in women at high risk for breast cancerElizabeth Tan-Chiu, Jiping Wang, Joseph P Costantino, et al.
Genes & Development|September 20, 2000
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcriptionJ Zhao, B K Kennedy, B D Lawrence, et al.
Complementary Therapies in Medicine|August 17, 2006
A Phase II study of St. John's Wort for smoking cessationSilvana Lawvere, Martin C Mahoney, K Michael Cummings, et al.
Neuropsychologia|April 5, 2002
Reading the mind from eye gazeAndrew J Calder, Andrew D Lawrence, Jill Keane, et al.
Pageof 108